Dr. Tasso Milliotis, Principal Scientist at AstraZeneca, has already experienced the remarkable benefits of these new columns: ...

Groundbreaking results from AstraZeneca’s Phase III SERENA-6 trial reveal a significant leap forward in the treatment of ...

AstraZeneca reports major survival benefits in breast and gastric cancer trials with Enhertu, Imfinzi, and camizestrant at ...